BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: . Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med 2022;386:1766-8. [DOI: 10.1056/nejmc2202778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mannucci A, D’amico F, El Saadi A, Peyrin-biroulet L, Danese S. Filgotinib for moderately to severely active ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2022. [DOI: 10.1080/17474124.2022.2138857] [Reference Citation Analysis]
2 Zhao Z, He S, Yu X, Lai X, Tang S, Mariya M. EA, Wang M, Yan H, Huang X, Zeng S, Zha D. Analysis and Experimental Validation of Rheumatoid Arthritis Innate Immunity Gene CYFIP2 and Pan-Cancer. Front Immunol 2022;13:954848. [DOI: 10.3389/fimmu.2022.954848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]